Clinical Trials
4 trialsNCT00824733 2016-01-14
Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Terminated
NCT00471159 2015-05-04
A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.
Pfizer
Phase 2 Withdrawn
NCT00043368 2009-03-12
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
Pfizer
Phase 2 Completed
NCT00043394 2009-03-12
CPG 7909 Plus HerceptinĀ® In Patients With Metastatic Breast Cancer
Pfizer
Phase 2 Completed